PL BioScience announces Distributorship Agreement with SPI PL BioScience announces Exclusive Distributorship Agreement with Summit Pharmaceuticals International (SPI) PL BioScience GmbH is proud to announce an exclusive distribution agreement for the Japanese market with Summit Pharmaceuticals International Corporation (SPI) to support local availability of Gamma-Irradiated ELAREM™ Ultimate-FD
PL BioScience announces Material Qualification Certificate from Japan's PMDA PL BioScience announces Material Qualification Certificate for ELAREM™ Ultimate-FD PLUS from Japan's PMDA PL BioScience announced that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has issued a Material Qualification Certificate for ELAREM™ Ultimate-FD PLUS (GMP Grade), the company’s processed cell culture
PL BioScience announces new Board Member PL BioScience announces Ole Henrik Bang-Andreasen as the newest Member of the Board PL BioScience has revealed that Ole Henrik Bang-Andreasen has been appointed to its Board of Directors, following the passing of board member Reinhard Vogt. Ole brings significant experience and
PL BioScience Reveals Fall 2025 Conferences Attendance PL BioScience announces participation in upcoming conferences this fall PL BioScience has revealed its participation in six upcoming Fall 2025 conferences. As part of its global strategy, the company will be represented in the following conferences in Asia and Europe:
PL BioScience Announces Major Site Expansion in September 2025 Key Milestone for PL BioScience as new headquarters are announced PL BioScience announced the next major step in its expansion – an upcoming move to a new 1,200 m² facility in Aachen, in September 2025. This key milestone
